ATI RN
ATI Nurs 180 Pharmacology Quiz Questions
Extract:
Question 1 of 5
A nurse is providing teaching to a client who is taking raloxifene (Evista) to prevent postmenopausal osteoporosis. Which of the following options DOES NOT indicate an adverse effect of this medication?
Correct Answer: C
Rationale: The correct answer is C: Jaundice. Raloxifene is not known to cause jaundice as an adverse effect. Redness, swelling, and tenderness in the lower leg could indicate deep vein thrombosis, a potential serious adverse effect of raloxifene. Jaundice is not typically associated with raloxifene use and is more commonly linked to liver-related issues or certain medications.
Therefore, if a client experiences jaundice while taking raloxifene, it is important to investigate other potential causes and consider discontinuing the medication.
Question 2 of 5
A new client has been admitted to the hospital and reported taking acetaminophen (Tylenol) at home. The nurse should identify that which of the following conditions is contraindicated for acetaminophen (Tylenol)?
Correct Answer: A
Rationale: The correct answer is A: Alcohol use disorder. Acetaminophen is metabolized in the liver, and chronic alcohol use can lead to liver damage. Combining acetaminophen with alcohol can increase the risk of liver toxicity and liver failure. Asthma (
B), diabetes (
C), and heart failure (
D) are not contraindications for acetaminophen. Asthma and diabetes do not directly interact with acetaminophen, and acetaminophen is considered safe for use in heart failure patients as it does not worsen the condition.
Question 3 of 5
A nurse is planning care for a client who has completed a detoxification from opioid abuse disorder. The nurse should expect a prescription for which of the following medications for the treatment of opioid abuse?
Correct Answer: D
Rationale: The correct answer is D: Methadone (Methacose). Methadone is commonly used in the treatment of opioid use disorder due to its ability to reduce withdrawal symptoms and cravings without producing the euphoria associated with opioids. It helps stabilize the client and minimize the risk of relapse. Morphine sulfate (
A) and Fentanyl (
B) are potent opioids and not typically used in opioid use disorder treatment. Naltrexone (
C) is an opioid antagonist that is used for relapse prevention after detoxification, not during initial treatment.
Question 4 of 5
A nurse is preparing to administer naloxone (Narcan). The nurse understands that this medication has a rapid first-pass inactivation. Which of the route should the nurse NOT administer this medication?
Correct Answer: C
Rationale: The correct answer is C: Oral (PO). Naloxone has a rapid first-pass inactivation when administered orally, as it gets extensively metabolized by the liver before reaching systemic circulation.
Therefore, administering naloxone orally would result in reduced effectiveness due to the liver's metabolism. Subcutaneous (
A), intravenous (
B), and intramuscular (
D) routes bypass the liver initially, allowing naloxone to reach systemic circulation quickly and effectively. Hence, these routes are suitable for administering naloxone in emergency situations where rapid action is required.
Question 5 of 5
A nurse is caring for a client with a new prescription for alendronate (Fosamax). Which of the following symptoms indicate a possible complication of this medication?
Correct Answer: C
Rationale: The correct answer is C: Dysphagia. Alendronate can cause esophagitis and esophageal ulcers, leading to dysphagia or difficulty swallowing. This occurs due to the medication's potential to irritate the esophagus if not taken correctly. Inflammation on the calf (
A) is unrelated to alendronate. Drowsiness (
B) is not a common side effect of the medication. Nausea (
D) can occur but is not a specific complication of alendronate.